Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ace393 (1 trial)
ace527 (2 trials)
campylobacter jejuni strain bh-01-0142 (1 trial)
campylobacter jejuni strain cg8421 (1 trial)
Campylobacter Infections (Phase 2)
Diarrhea (Phase 2)
Infections (Phase 2)
Trials (4 total)
Trial APIs (4 total)